The following are the abstracts for sessions where we have asked panellists to prepare presentations in advance, addressing some of the issues indicated, to ensure that the time available in each session is used for Q&A and discussion with conference participants.
Why does it appear to be impossible to conduct a proper, reasoned and scientific debate about the effectiveness of safer nicotine products in encouraging smokers to switch from a proven dangerous alternative?
We ask panellists, in both their pre-recorded presentations and in their contributions to the live discussions during the session, to focus on ‘roadblocks’ they see as important to address. Reflections from their own personal experience in this space are welcome. Some possible issues might be:
Up to seven days before the live event, the pre-recorded videos provided by each panellist will be made available online to the audience, who will be encouraged to watch them in advance of the live discussions.
Panellists are encouraged to highlight just 2-3 issues (maximum) in their pre-recorded presentations. Pre-recorded presentations longer than the ten minute limit will not be accepted for broadcast.
We anticipate 40 minutes for the discussion, with questions from the session hosts and from the live and online audience.
This session will draw on our panellists’ varied and extensive expertise for a thought-provoking, ‘grown-up’ discussion about who uses nicotine, in its various forms, and why.
We ask panellists, in both their pre-recorded presentations and in their contributions to the live discussions during the session, to focus on the aspects they see as important to address. Some possible areas for discussion might be:
Up to seven days before the live event, the pre-recorded videos provided by each panellist will be made available online to the audience, who will be encouraged to watch them in advance of the live discussions.
Panellists are encouraged to highlight just 2-3 issues (maximum) in their pre-recorded presentations. Pre-recorded presentations longer than the ten minute limit will not be accepted for broadcast.
We anticipate 40 minutes for the discussion, with questions from the session hosts and from the live and online audience.
This session will examine the issues surrounding tobacco harm reduction in LMICs and why smokers in LMICs are being denied the opportunity to access safer nicotine products.
We ask panellists, in both their pre-recorded presentations and in their contributions to the live discussions during the session, to focus on the ‘roadblocks’ they see as important to address. Some possible areas for discussion might be:
Up to seven days before the live event, the pre-recorded videos provided by each panellist will be made available online to the audience, who will be encouraged to watch them in advance of the live discussions.
Panellists are encouraged to highlight just 2-3 issues (maximum) in their pre-recorded presentations. Pre-recorded presentations longer than the ten minute limit will not be accepted for broadcast.
We anticipate 40 minutes for the discussion, with questions from the session hosts and from the live and online audience.
This session will look at the broad issues surrounding regulation and whether it is a hindrance or a benefit for the consumer.
We ask panellists, in both their pre-recorded presentations and in their contributions to the live discussions during the session, to focus on the ‘roadblocks’ they see as important to address. Some possible areas for discussion might be:
Up to seven days before the live event, the pre-recorded videos provided by each panellist will be made available online to the audience, who will be encouraged to watch them in advance of the live discussions.
Panellists are encouraged to highlight just 2-3 issues (maximum) in their pre-recorded presentations. Pre-recorded presentations longer than the ten minute limit will not be accepted for broadcast.
We anticipate 40 minutes for the discussion, with questions from the session hosts and from the live and online audience.
KAC-Communications the organiser of GFN is committed to providing a platform for global public health debate, knowledge exchange and networking, underpinned by the principles of inclusiveness and multi-sectoral engagement.
#GFN22 Tobacco Harm Reduction - Here for Good Safer Nicotine Products The Future for Nicotine
Conference, Website, Logos and the Conference Name © 2014-2022 KAC-Communications
The conference does not receive any sponsorship from manufacturers, distributors or retailers of nicotine products including pharmaceutical, electronic cigarette and tobacco companies. Conference supporting organisations endorse the event but have no financial or administrative involvement in organisation of the event.
© Copyright 2014 - 2022 KAC•Communications
All Rights Reserved